Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach.

Gastrointestinal stromal tumors are relatively rare soft-tissue neoplasms arising from the gastrointestinal tract. The clinical presentation of gastrointestinal stromal tumors varies and depends on the tumor size and location. We present 2 patients with a gastrointestinal stromal tumor who presented with genitourinary symptoms and were diagnosed by transrectal ultrasound-guided prostate biopsy. We describe the clinical presentation and diagnostic and therapeutic approach to these cases, highlighting the successful preoperative use of imatinib mesylate (Gleevec) followed by prostatectomy.

[1]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[2]  R. Sciot,et al.  Gastrointestinal stromal tumor of the prostate. , 2005, Urology.

[3]  A. Agaimy,et al.  Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation , 2006, Langenbeck's Archives of Surgery.

[4]  D. Tuveson,et al.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. , 2001, The New England journal of medicine.

[5]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[6]  J. Blay,et al.  Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[7]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[8]  Chi-Ming Lee,et al.  Gastrointestinal stromal tumor of the prostate: a case report and literature review. , 2006, Human pathology.

[9]  Xin Huang,et al.  Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial , 2006, The Lancet.

[10]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[11]  Sigrid Stroobants,et al.  Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study , 2001, The Lancet.